RP Cure Tracker

Trials / NCT01866371

High Resolution Retinal Imaging

Recruiting now Observational Natural history / observational

Sponsor
University of Pennsylvania
Treatment
Retinal imaging
Gene
Not stated
Conditions
Stargardts, Retinitis Pigmentosa, Age-related Macular Degeneration, Choroideremia, Geographic Atrophy
Ages
7 Years to no upper limit
Enrollment
600 participants
Started
2013-05
Main results expected
2030-12
Results posted
Not yet
Record last updated
2026-05-05

What the study is testing

Studying the morphology and function of the normal and diseased retina in vivo is needed for advancing the detection, diagnosis, and treatment of retinal disease. This protocol uses an adaptive optics scanning laser ophthalmoscope (AOSLO) to image the normal and diseased retina with individual cellular resolution non-invasively. The primary objective of this study is to obtain and analyze high-resolution images of the retina, in particular by imaging the cone photoreceptor mosaic, the retinal vasculature and other retinal layers. The study design will involve case-control studies, where cases are followed over time. Subjects age 7 and older may be invited to participate. The main research procedure involves retinal imaging with the AOSLO. The primary endpoint is the observation of differences in retinal images between subjects with and without retinal diseases. These changes will be quantified by examining the cell density, size, spacing and regularity of the cone photoreceptor mosaic, as well as examining the differences between other retinal layers.

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility